These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Value of granulocyte colony stimulating factor in radiotherapy induced neutropenia: clinical and laboratory studies. Mac Manus MP, McCormick D, Trimble A, Abram WP. Eur J Cancer; 1995; 31A(3):302-7. PubMed ID: 7540401 [Abstract] [Full Text] [Related]
4. Low-dose recombinant human granulocyte colony-stimulating factor therapy in children with symptomatic chronic idiopathic neutropenia. Bernini JC, Wooley R, Buchanan GR. J Pediatr; 1996 Oct; 129(4):551-8. PubMed ID: 8859262 [Abstract] [Full Text] [Related]
5. Comparison of the potency of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factors in neutropenic and nonneutropenic CD rats. Nohynek GJ, Plard JP, Wells MY, Zerial A, Roquet F. Cancer Chemother Pharmacol; 1997 Oct; 39(3):259-66. PubMed ID: 8996530 [Abstract] [Full Text] [Related]
6. [Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial]. Yang S, Shi YK, Liu P, Han XH, He XH, Cai YM, Chen ZM. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):339-44. PubMed ID: 16900629 [Abstract] [Full Text] [Related]
8. Difference in the responses after administration of granulocyte colony-stimulating factor in septic patients with relative neutropenia. Ishikawa K, Tanaka H, Nakamori Y, Hosotsubo H, Ogura H, Nishino M, Shimazu T, Sugimoto H. J Trauma; 2000 May; 48(5):814-24; discussion 824-5. PubMed ID: 10823524 [Abstract] [Full Text] [Related]
9. Treatment of myelodysplastic syndrome with low-dose human granulocyte colony-stimulating factor: a multicenter study. Chuncharunee S, Intragumtornchai T, Chaimongkol B, Prayoonwiwat W, Leelasiri A, Lekhakula A, Chansung K, Yoshida Y. Int J Hematol; 2001 Aug; 74(2):144-6. PubMed ID: 11594513 [Abstract] [Full Text] [Related]
10. [Clinical evaluation of recombinant human G-CSF in children with cancer]. Tsukimoto I, Hanawa Y, Takaku F, Asano S, Ueda K, Tsuchida M, Sato T, Ohira M, Hoshi Y, Nishihira K. Rinsho Ketsueki; 1990 Oct; 31(10):1647-55. PubMed ID: 1701501 [Abstract] [Full Text] [Related]
12. Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type Ib. Schroten H, Roesler J, Breidenbach T, Wendel U, Elsner J, Schweitzer S, Zeidler C, Burdach S, Lohmann-Matthes ML, Wahn V. J Pediatr; 1991 Nov; 119(5):748-54. PubMed ID: 1719175 [Abstract] [Full Text] [Related]
13. Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropenia. Carlsson G, Ahlin A, Dahllöf G, Elinder G, Henter JI, Palmblad J. Br J Haematol; 2004 Jul; 126(1):127-32. PubMed ID: 15198743 [Abstract] [Full Text] [Related]
14. Pharmacokinetics of glycosylated recombinant human granulocyte colony-stimulating factor (lenograstim) in healthy male volunteers. Houston AC, Stevens LA, Cour V. Br J Clin Pharmacol; 1999 Mar; 47(3):279-84. PubMed ID: 10215752 [Abstract] [Full Text] [Related]
19. Use of recombinant human granulocyte colony-stimulating factor in children given allogeneic bone marrow transplantation for acute or chronic leukemia. Locatelli F, Pession A, Zecca M, Bonetti F, Prete L, Carrà AM, Prete A, Montagna D, Comoli P, Taibi RM, Paolucci G. Bone Marrow Transplant; 1996 Jan; 17(1):31-7. PubMed ID: 8673051 [Abstract] [Full Text] [Related]
20. A comparative trial of granulocyte-colony-stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteers. Liles WC, Huang JE, Llewellyn C, SenGupta D, Price TH, Dale DC. Transfusion; 1997 Feb; 37(2):182-7. PubMed ID: 9051093 [Abstract] [Full Text] [Related] Page: [Next] [New Search]